
A study presented at the IASLC 2024 World Conference on Lung Cancer investigated the benefit of a personalized music therapy regimen to improve perioperative pain and anxiety levels in patients with non-small cell lung cancer (NSCLC).
“Music therapy, with its advantages of high safety and absence of side effects, has gradually been accepted and applied in medical practice to alleviate patients’ negative emotions and feelings,” the investigators wrote. “However, there is a lack of in-depth empirical research on the specific impact of music therapy on perioperative anxiety in patients with NSCLC.”
To assess the benefit of this therapeutic option, the researchers conducted a single-center, open-label, phase 2 trial of 45 patients with stage I or II NSCLC. Thirty patients were randomized to receive a personalized music therapy regimen in addition to a patient-controlled analgesia (PCA) pump.